These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11209286)

  • 1. New Rx for psychoses in Alzheimer's, Parkinson's.
    Targum SD
    Contemp Longterm Care; 2001 Jan; 24(1):39-40. PubMed ID: 11209286
    [No Abstract]   [Full Text] [Related]  

  • 2. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine.
    Link S; Paulus W; Bandelow B
    Mov Disord; 2009 Dec; 24(16):2431-2. PubMed ID: 19890998
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations on the drug treatment of psychosis in Parkinson's disease.
    Friedman JH
    Am J Med; 2010 Apr; 123(4):e19; author reply e21. PubMed ID: 20362738
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs may help treat psychoses.
    Katz IR; Streim J
    Provider; 1995 Jul; 21(7):80, 83-4. PubMed ID: 10172362
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
    López del Val LJ; Santos S
    Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
    Stephani C; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
    [No Abstract]   [Full Text] [Related]  

  • 8. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease.
    Prueter C; Habermeyer B; Norra C; Kosinski CM
    Mov Disord; 2003 Jun; 18(6):712-3. PubMed ID: 12784279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic drugs and Alzheimer's disease.
    Jockers-Scherübl MC; Hellweg R
    N Engl J Med; 2007 Jan; 356(4):416-7; author reply 417-8. PubMed ID: 17256186
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of quetiapine in elderly patients.
    Tariot PN; Ismail MS
    J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
    Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
    Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 16. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 17. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic use in older adults with Parkinson's disease.
    Marras C; Kopp A; Qiu F; Lang AE; Sykora K; Shulman KI; Rochon PA
    Mov Disord; 2007 Feb; 22(3):319-23. PubMed ID: 17149718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.